Fatigue or drowsiness: Some users report feeling tired after injection, particularly with evening dosing
He noted that GLP-1 medications are not suitable for patients with a history of pancreatitis, medullary thyroid cancer and/or gallstones
PT-141 (bremelanotide, Vyleesi) is approved by the FDA only for acquired, generalized hypoactive sexual desire disorder in premenopausal women, and its approved indication explicitly excludes low desire due to a co-existing psychiatric condition (such as depression) or the effects of a medication (such as an antidepressant)
Ill be sharing more in future articles and upcoming books, but for this article, lets talk briefly about the carnitine and metabolic connections seen in other conditions
This means that you shouldnt inject medication into the same spot twice in a row
as well as multifactorial cardiovascular treatmentan intervention focused on eliminating additional neuropathy risk factors, particularly dyslipidemia and smoking cessation